Keith B. Hoffman

1.4k citations

25 papers · 1.1k indexed · h-index 19

Cellular and Molecular Neuroscience top 5%
Molecular Biology
Physiology top 10%
Toxicology top 1%
Cell Biology top 10%

Co-authors: Gary Lynch Mo Dimbil Ben A. Bahr Nicholas P. Tatonetti Christine M. Gall Charles Glabe Beatrice A. Golomb Peter W. Vanderklish
Topics: Neuroscience and Neuropharmacology Research (13 papers)Lipid Membrane Structure and Behavior (6 papers)Alzheimer's disease research and treatments (5 papers)
Cited by: Toxicology Cellular and Molecular Neuroscience Developmental Neuroscience
Journals: PLoS ONE The Journal of Comparative Neurology Brain Research
Partner nations: United States

In The Last Decade

Keith B. Hoffman

25 papers receiving 1.1k citations

Peers

Replace Robert B. MacArthur with:

Robert B. MacArthur United States

Cristiana Stefan Canada

Stanley Cohan United States

Anthony C. Sulpizio United States

Qilin Zhang China

R. Howard Zobrist United States

Eseng Lai United States

Yuh‐Lih Chang Taiwan

Cuiling Ma China

Philip Janiak France

Keith B. Hoffman relative to Robert B. MacArthur United States Robert B. MacArthur's profile →

Citations per field

00.5×2×4×5.2×

Robert B. MacArthur · 1×

×2.0 344/169

CMN

×0.9 330/362

MB

×1.5 274/183

PHYSI

×5.2 150/29

TOXIC

×2.1 129/61

CB

Citations per year

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

Countries citing papers authored by Keith B. Hoffman

Since Specialization

Citations

This map shows the geographic impact of Keith B. Hoffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith B. Hoffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith B. Hoffman more than expected).

Fields of papers citing papers by Keith B. Hoffman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith B. Hoffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith B. Hoffman. The network helps show where Keith B. Hoffman may publish in the future.

Co-authorship network of co-authors of Keith B. Hoffman

This figure shows the co-authorship network connecting the top 25 collaborators of Keith B. Hoffman. A scholar is included among the top collaborators of Keith B. Hoffman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith B. Hoffman. Keith B. Hoffman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System 2019 ·Drugs - Real World Outcomes ·Matthew S. Duprey,Nada S. Al‐Qadheeb,J. Nicholas O’Donnell,Keith B. Hoffman,Jonathan Weinstock,Christopher Madias,Mo Dimbil,John W. Devlin	5
2	Amyotrophic Lateral Sclerosis Associated with Statin Use: A Disproportionality Analysis of the FDA’s Adverse Event Reporting System 2018 ·Drug Safety ·Beatrice A. Golomb,(unknown),(unknown),Hayley J. Koslik,Keith B. Hoffman	27
3	Analysis of Spontaneous Postmarket Case Reports Submitted to the FDA Regarding Thromboembolic Adverse Events and JAK Inhibitors 2017 ·Drug Safety ·(unknown),Mo Dimbil,(unknown),(unknown),Keith B. Hoffman	110
4	A Pharmacovigilance Signaling System Based on FDA Regulatory Action and Post-Marketing Adverse Event Reports 2016 ·Drug Safety ·Keith B. Hoffman,Mo Dimbil,Nicholas P. Tatonetti,(unknown)	26
5	A Drug Safety Rating System Based on Postmarketing Costs Associated with Adverse Events and Patient Outcomes 2015 ·Journal of Managed Care & Specialty Pharmacy ·Keith B. Hoffman,Mo Dimbil,(unknown),Nicholas P. Tatonetti,(unknown),(unknown),(unknown),(unknown)	5
6	Stimulated Reporting: The Impact of US Food and Drug Administration-Issued Alerts on the Adverse Event Reporting System (FAERS) 2014 ·Drug Safety ·Keith B. Hoffman,(unknown),Mo Dimbil,Nicholas P. Tatonetti,(unknown)	85
7	The Weber Effect and the United States Food and Drug Administration’s Adverse Event Reporting System (FAERS): Analysis of Sixty-Two Drugs Approved from 2006 to 2010 2014 ·Drug Safety ·Keith B. Hoffman,Mo Dimbil,(unknown),Nicholas P. Tatonetti,(unknown)	131
8	Development of a drug safety ePlatform for physicians, pharmacists, and consumers based on post-marketing adverse events 2013 ·Keith B. Hoffman,(unknown),P. Murali Doraiswamy	7
9	A Survey of the FDA's AERS Database Regarding Muscle and Tendon Adverse Events Linked to the Statin Drug Class 2012 ·PLoS ONE ·Keith B. Hoffman,Christina N. Kraus,Mo Dimbil,Beatrice A. Golomb	93
10	Delayed and isoform-specific effect of NMDA exposure on neural cell adhesion molecules in hippocampus 2001 ·Neuroscience Research ·Keith B. Hoffman,Ben A. Murray,Gary Lynch,(unknown),Ben A. Bahr	23
11	Peripheral administration of a serine protease inhibitor blocks kindling 2000 ·Brain Research ·Keith B. Hoffman,(unknown),John Larson,Gary Lynch	6
12	β-Amyloid increases cathepsin D levels in hippocampus 1998 ·Neuroscience Letters ·Keith B. Hoffman,Xiaoning Bi,(unknown),Gary Lynch	19
13	The Relationship Between Adhesion Molecules and Neuronal Plasticity 1998 ·Cellular and Molecular Neurobiology ·Keith B. Hoffman	35
14	Seizure induced synthesis of fibronectin is rapid and age dependent: implications for long-term potentiation and sprouting 1998 ·Brain Research ·Keith B. Hoffman,Jason Pinkstaff,Christine M. Gall,Gary Lynch	42
15	Activation of NMDA receptors stimulates extracellular proteolysis of cell adhesion molecules in hippocampus 1998 ·Brain Research ·Keith B. Hoffman,John Larson,Ben A. Bahr,Gary Lynch	36
16	Mannose-specific lectins modulate ligand binding to AMPA-type glutamate receptors 1998 ·Brain Research ·Keith B. Hoffman,Markus Kessler,(unknown),Lien Lam,Gary Lynch	11
17	Proteolysis of cell adhesion molecules by serine proteases: a role in long term potentiation? 1998 ·Brain Research ·Keith B. Hoffman,(unknown),Gary Lynch	47
18	Distinct distributions of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor subunits and a related 53,000 Mr antigen (GR53) in brain tissue 1996 ·Neuroscience ·Ben A. Bahr,Keith B. Hoffman,Markus Kessler,(unknown),(unknown),Reiko Yamamoto,Brian T. Kawasaki,Peter W. Vanderklish,Randy A. Hall,Gary Lynch	27
19	Stable maintenance of glutamate receptors and other synaptic components in long‐term hippocampal slices 1995 ·Hippocampus ·Ben A. Bahr,Markus Kessler,Santiago Rivera,Peter W. Vanderklish,Randy A. Hall,(unknown),Christine M. Gall,Keith B. Hoffman	83
20	Induction of β-Amyloid-Containing Polypeptides in Hippocampus: Evidence for a Concomitant Loss of Synaptic Proteins and Interactions with an Excitotoxin 1994 ·Experimental Neurology ·Ben A. Bahr,Babak Abai,Christine M. Gall,Peter W. Vanderklish,Keith B. Hoffman,Gary Lynch	69

About Keith B. Hoffman

Keith B. Hoffman is a scholar working on Toxicology, Cellular and Molecular Neuroscience and Developmental Neuroscience, having authored 25 papers that have together received 1.1k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (13 papers), Lipid Membrane Structure and Behavior (6 papers) and Alzheimer's disease research and treatments (5 papers). The work is most often cited by research in Toxicology (150 citations), Cellular and Molecular Neuroscience (344 citations) and Developmental Neuroscience (77 citations). Keith B. Hoffman has collaborated with scholars based in United States. Frequent co-authors include Gary Lynch, Mo Dimbil, Ben A. Bahr, Nicholas P. Tatonetti, Christine M. Gall, Charles Glabe, Beatrice A. Golomb, Peter W. Vanderklish, Markus Kessler and Christina N. Kraus. Their work appears in journals such as PLoS ONE, The Journal of Comparative Neurology and Brain Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact